
    
      Subjects will receive 1 of 4 treatments per period and will eventually receive all 4
      treatments:

      Treatment A: ER niacin 2g/laropiprant 40 mg daily + Placebo to laropiprant for 7 days

      Treatment B: ER niacin 2 g daily + Placebo to laropiprant for 7

      days

      Treatment C: laropiprant 40 mg daily + Placebo to ER niacin/laropiprant for 7 days

      Treatment D: placebo daily for 7 days. There will be at least a 7-day interval between dosing
      on Day 7 of a period and dosing on Day 1 of the subsequent period
    
  